TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02732197

Intervention type: DRUG
Intervention: Sedation
Description: Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).

Intervention type: DRUG
Intervention: No sedation
Description: Parturients did not receive any type of sedation after spinal anesthesia.
Study: NCT00919841

Intervention type: OTHER
Intervention: Ultrasound examination
Description: Sequential three-dimension sonographic examination for the uterine size after vaginal delivery. The examination will be performed once a week, until the completion of 7 weeks after delivery.
Study: NCT02025452

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: Lactobacillus reuteri suspended in vegetable oil, 5 drops/day (1 x 10e8 CFU) x 2 months

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Identical in appearance to L. reuteri probiotic (same bottle), but simply vegetable oil. Dose is 5 drops/day x 2 months.
Study: NCT01347580

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Description: Oral Ticagrelor loading dose (180 mg) followed by matching placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo followed by oral Ticagrelor loading dose (180 mg)
Study: NCT00333203

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Next Generation Ophthalmic Irrigating Solution (NGOIS)
Description: Volume sufficient to irrigate adequately during cataract surgery

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BSS Plus
Description: Volume sufficient to irrigate adequately during cataract surgery
Study: NCT02316873

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music training
Description: This program was based on the Kodaly and Orff pedagogy and adapted to focus on rhythm and temporal processing.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Visual arts
Description: This program emphasized visual-spatial and hand skills as well as creativity.
Study: NCT00844168

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib tosylate
Description: Given orally

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT03386253

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active tDCS
Description: two 13 minute tDCS sessions separated by 20 minutes in between

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tDCS
Description: sham tDCS session given for same length of time as active
Study: NCT03117088

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Checklist ISBAR3
Description: Checklist ISBAR 3~Use of an online based checklist for handovers with the following items:~Identification Situation Background Assessment Recommendation Read- back Risk~Established Checklist as communication tool

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Checklist VICUR
Description: Checklist Vicur~Use of an online based alternative checklist for handovers with the following items:~Vaccination status Insurance status Contact person Utilisation Rehabilitation Organ donor? Patient decree?~alternative checklist missing communication tool
Study: NCT03493815

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transabdominal Ultrasound Guided IUD Insertion
Description: Comparing the utility of ultrasound-guided intrauterine device (IUD) insertion compared to traditional blind insertion

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Blind IUD Insertion
Description: Comparing the utility of ultrasound-guided intrauterine device (IUD) insertion compared to traditional blind insertion
Study: NCT02919969

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks.
Study: NCT01842633

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol and Caffeine
Description: Caplets containing 500 milligrams (mg) of paracetamol and 65 mg of caffeine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Caplets containing 200 mg of ibuprofen

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo caplets
Study: NCT00003830

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional surgery
Description: Sentinel node resection immediately followed by axillary dissection.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel node resection followed by node examination
Description: Sentinel node resection followed by node examination then axillary dissection if positive sentinel node. No axillary dissection for negative sentinel node.
Study: NCT03811093

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Care as Usual Group
Description: Each participant randomly assigned to the Care As Usual Group will undergo nine therapy sessions over three weeks using a fully functioning invisa-RED Technology Elite device.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Group
Description: Each participant randomly assigned to the Sham Group will undergo nine therapy sessions over three weeks using a non functioning invisa-RED Technology Elite device.
Study: NCT00559494

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Minocycline IV BID x 7 days (first 10 patients 200 mg/dose, subsequent patients adjusted based on pharmacodynamic profiling to 800 mg loading dose, tapered 100 mg each dose to 400 mg then maintain at 400mg until day 7)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Normal saline 250cc via central line similar to minocycline arm administration protocol

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SCPP augmentation
Description: maintenance of spinal cord perfusion pressure at 75 mmHg with fluids and inotrope protocol

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: SCPP control
Description: maintenance of Mean arterial pressure of \>65 mmHg with fluids and inotropes protocol without spinal cord perfusion pressure as target or guiding therapy
Study: NCT02025452

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Identical in appearance to L. reuteri probiotic (same bottle), but simply vegetable oil. Dose is 5 drops/day x 2 months.
Study: NCT04030286

Intervention type: OTHER
Intervention: Observation
Description: Evaluation of Malondialdehyde level and correlation of Malondialdehyde level with periodontal and cardiovascular disease

Intervention type: OTHER
Intervention: Observation
Description: Evaluation of Malondialdehyde level and correlation of Malondialdehyde level with periodontal and cardiovascular disease
Study: NCT01239862

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous cell transplantation
Description: Intrabronchial Instillation Of Bone Marrow Derived Mononuclear Cells
Study: NCT00541788

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Administration of Common Sage
Description: Administration of Common Sage
Study: NCT03235739

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxegol 25 MG
Description: Oral Naloxegol 25 MG

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching oral placebo
Study: NCT04533893

Intervention type: OTHER
Intervention: Medical simulator (3B Scientific Lilly Pro) and Platform combining simulator sensor data with OSCE scores
Description: Hands-on training app combining OSCE scoring criteria with sensor data retrieved from the simulator's sensors was used for hands-on performance evaluation.
Study: NCT03864575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg
Description: Celecoxib 400 mg/day in combination with nivolumab fixed dose
Study: NCT02360761

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VATS
Description: Patients undergo lobectomy,wedge resection, or anatomical segmentectomy by thoracoscopic surgery or video assisted thoracoscopic surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VATS
Description: Patients undergo lobectomy,wedge resection, or anatomical segmentectomy by thoracoscopic surgery or video assisted thoracoscopic surgery.
Study: NCT04675112

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT) and Tinnitus Retraining Therapy (TRT)
Description: CBT is a psychologically informed treatment. Depending on individual patient needs, relevant areas of tinnitus education and management/self-management strategies, such as managing the emotional consequences of tinnitus, rapid relaxation, managing fear and avoidance behaviors and changing unhelpful thoughts and beliefs, are applied in accordance to a published manual \[10\].~TRT is based on the neurophysiological model focusing more on education and sound therapy than on analytical cognitive and behavioral interventions. A TRT program is usually included in a management scheme with hearing aids.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Treatment (CBT) and Tinnitus Retraining Therapy (TRT)
Description: CBT is a psychologically informed treatment. Depending on individual patient needs, relevant areas of tinnitus education and management/self-management strategies, such as managing the emotional consequences of tinnitus, rapid relaxation, managing fear and avoidance behaviors and changing unhelpful thoughts and beliefs, are applied in accordance to a published manual \[10\].~TRT is based on the neurophysiological model focusing more on education and sound therapy than on analytical cognitive and behavioral interventions. A TRT program is usually included in a management scheme with hearing aids.
Study: NCT01818141

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: Vancomycin 125mg by mouth every 6 hours for 10 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fidaxomicin
Description: Fidaxomicin 200mg by mouth every 12 hours for 10 days
Study: NCT01740336

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching to GDC-0941
Study: NCT02948348

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Capecitabine:Dose of 1650mg/m2,14days, Radiation:45Gy/25 fractions, Nivolumab :240mg on day1 of each cycle, Surgical therapy:The resection (LAR), intersphincteric resection (ISR), or abdominoperineal resection (APR).
Study: NCT01740336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered IV weekly for 3 out of 4 weeks in every 28-day cycle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel will be administered IV weekly for 3 out of 4 weeks in every 28-day cycle.
Study: NCT02948348

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: For only Cohort D,1 mg/kg at six-week intervals
Study: NCT03849716

Intervention type: OTHER
Intervention: Blood sample
Description: Blood samples obtained for biomarker analyses

Intervention type: OTHER
Intervention: Cheek swab
Description: Cheek swab obtained for genetic analysis
Study: NCT03444220

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Anaerobically Cultivated Human Intestinal Microbiota
Description: 30ml ACHIM will be administrated at week 0 and 2 with 14 days apart

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Anaerobically Cultivated medium
Description: 30ml medium will be administrated at week 0 and 2 with 14 days apart
Study: NCT02711176

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nexium
Description: Patients in experimental group will receive the 14 day single dose of Nexium 40 mg daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinafas
Description: Patients in experimental group will receive the 14 day single dose regimen of Tinafas 1 g daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tavanex
Description: Patients in experimental group will receive the 14 day single dose of Tavanex 500 mg daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lanzol
Description: Patients in active comparator group will receive the 14 day lansoprazole (Lanzol) 30 mg twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Klacid
Description: Patients in active comparator group will receive the 14 day clarithromycin (Klacid) 500 mg twice daily twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iramox
Description: Patients in active comparator group will receive the 14 day amoxicillin (Iramox) 1 g twice daily
Study: NCT02707770

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pulmonary Rehabilitation
Study: NCT03450213

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Pentacam
Description: Pentacam will be used to measure the magnitude and axis orientation of anterior and posterior corneal astigmatism.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pentacam
Description: Pentacam will be used to measure the magnitude and axis orientation of anterior and posterior corneal astigmatism.
Study: NCT03059693

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAT1 topical cream

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle cream
Study: NCT03673371

Intervention type: OTHER
Intervention: Questionnaire
Description: This is a questionnaire developed by DoD and VA researchers specifically for this study.
Study: NCT02320786

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoPILOT
Description: Participants in both groups will receive twelve hours of training in a standard powered wheelchair however the CoPILOT groups will use remote control technology we have developed. The technology provides the trainer with remote control of wheelchair speed and direction allowing the trainer to override the participant's actions as needed to ensure safe error-free shared controlled wheelchair training. The CoPILOT approach will accommodate varied learning needs, as per adult learning principles, while decreasing trainer input until the participant can complete tasks independently.
Study: NCT00027690

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefitinib
Description: Given orally

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study: NCT01542541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: 550mg BID for 2 days
Study: NCT02144649

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: dietary intervention (tangerine tomato juice)
Description: Group II will consume two 5.5 oz. cans of tangerine tomato juice every day until their scheduled surgery. (approximately 4 weeks).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: dietary intervention (red tomato juice)
Description: Group III will consume two 5.5 oz. cans of red tomato juice every day until their scheduled surgery (approximately 4 weeks).red tomato juice

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Men enrolled in the study will be asked to complete a 3-Day Food Record and a series of additional questionnaires (urologic symptom and quality of life questionnaire) at home.
Study: NCT01364402

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Description: 50,000U intravenously

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline 0.9%
Description: normal saline intravenously
Study: NCT04151693

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Psychological Group Rehabilitation for Patients With Chronic Fatigue Syndrome (ME/CFS)
Description: Adaptation (support own agency), rehabilitation and improvement of functional capacity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Psychological Group Rehabilitation for Patients With Chronic Fatigue Syndrome (ME/CFS)
Description: Adaptation (support own agency), rehabilitation and improvement of functional capacity.
Study: NCT03800966

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Leaflet
Description: Leaflets for both groups will be printed in colour. Leaflet in each group contains 8 pictures and 8 statement, whose sequences will be scrambled. Primary school students need to do the matching, to ensure they read the statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Leaflet
Description: Leaflets for both groups will be printed in colour. Leaflet in each group contains 8 pictures and 8 statement, whose sequences will be scrambled. Primary school students need to do the matching, to ensure they read the statements.
Study: NCT03241043

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment 2 weeks Envarsus followed by 2 weeks Advagraf

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
Study: NCT01315275

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Study: NCT04048070

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flurbiprofen Axetil
Description: One kind of NSAIDs, 200mg for 48 hours after surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flurbiprofen Axetil
Description: One kind of NSAIDs, 200mg for 48 hours after surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Extended perioperative counseling
Description: The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Extended perioperative counseling
Description: The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shorter fasting food and water time before surgery
Description: The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shorter fasting food and water time before surgery
Description: The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional perioperative counseling
Description: THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional perioperative counseling
Description: THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Conventional perioperative counseling
Description: THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.
Study: NCT02144649

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Men enrolled in the study will be asked to complete a 3-Day Food Record and a series of additional questionnaires (urologic symptom and quality of life questionnaire) at home.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Correlative studies
Description: Blood and urine samples at enrollment and blood, urine, and prostate tissue at the time of surgery to determine compliance with the intervention product and tomato phytochemical biodistribution. Additionally, we will correlate each type of tomato juice with lycopene presence in plasma, urine, and tissue provided by subjects on the day of surgery.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Correlative studies
Description: Blood and urine samples at enrollment and blood, urine, and prostate tissue at the time of surgery to determine compliance with the intervention product and tomato phytochemical biodistribution. Additionally, we will correlate each type of tomato juice with lycopene presence in plasma, urine, and tissue provided by subjects on the day of surgery.
Study: NCT02602509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Study: NCT04048070

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular fasting food and water time before surgery
Description: The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular fasting food and water time before surgery
Description: The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Regular fasting food and water time before surgery
Description: The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.
Study: NCT01863602

Intervention type: DRUG
Intervention: Lamotrigine tablets
Description: Administered for long-term according to the prescribing information in the locally approved label by the authorities.
Study: NCT03146481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aceclofenac
Description: Aceclofenac 100 mg tablet given one hour before starting the root canal treatment

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet given one hour before starting the root canal treatment
Study: NCT02602509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrazinamide
Study: NCT03220412

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movies with Guns
Description: Participants in this arm viewed movies (National Treasure, The Rocketeer) without guns. The movies, rated PG, were edited to remove guns from the scenes